Researchers have found that in just four years the HPV vaccine has resulted in a dramatic drop in genital warts in young Australians of all backgrounds, a result that could herald good news for cervical cancer rates.
Annual HIV funding from developed to developing countries is about $US18 billion, however this is still about $US5 billion a year short of what’s required to sustain the gains of the last decade, writes William Bowtell.
Joep Lange was a visionary leader and my friend. His legacy on HIV research will live on, but there remain huge hurdles. If Lange had any solutions they died with him over a field in eastern Ukraine, writes David Cooper.
Two men treated at St Vincent’s Hospital in partnership with UNSW's Kirby Institute have undetectable levels of HIV more than three years after their bone marrow transplants, the first successful cases of the HIV virus being cleared in Australia.
In responding to the needs of communities affected by HIV, it is vital that the response includes not just science and research but also people's social needs, write Andrew Grulich, Cheryl Overs and Peter Higgs.
Australia has long been seen as a world leader in HIV prevention, treatment and care, yet our academic sector has been underutilised when it comes to the delivery of international health aid, write David Cooper and John Kaldor.
HIV/AIDS is “not yesterday’s issue; it is not a problem that has gone away”, HIV campaigner Lord Norman Fowler has told a UNSW audience, arguing that the epidemic needs to be raised higher on the global health agenda.
Unlike plagues of the past, which have often been equalisers, indiscriminately killing nobility and working class, young and old, this modern plague kills very differently, write Michael Kirby and Mark Dybul.
Those rare people who never fall ill with AIDS despite being infected with HIV could be a key to developing a vaccine or even a cure, Nobel prize-winning virologist Françoise Barré-Sinoussi will tell a UNSW symposium.
Genetic mutations that affect our blood cells' haemoglobin are the most common of all mutations. Finding an effective treatment would eliminate the need for lifelong blood transfusions, writes Merlin Crossley.